SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,966.35 0.00
( 0.00%)

Global Indices

Nasdaq

53,790.86 -21.99
(-0.04%)

Dow Jones

7,769.71 20.51
(0.26%)

Hang Seng

67,546.56 576.34
(0.86%)

Nikkei 225

10,825.49 -18.70
(-0.17%)

Forex

USD-INR

95.28 0.13
(0.14%)

EUR-INR

110.05 0.08
(0.07%)

GBP-INR

128.64 0.30
(0.23%)

JPY-INR

0.60 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

43.3828165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

12.01

191.2

EPS(TTM)

Face Value()

Div & Yield %

10.08

0.58

Back

India Glycols consolidated net profit rises 18.94% in the December 2025 quarter

Feb 11,2026

Net profit of India Glycols rose 18.94% to Rs 67.57 crore in the quarter ended December 2025 as against Rs 56.81 crore during the previous quarter ended December 2024. Sales rose 13.04% to Rs 1102.40 crore in the quarter ended December 2025 as against Rs 975.20 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1102.40	975.20	13
OPM %	15.92	12.68	-
PBDT	132.66	98.89	34
PBT	91.44	71.42	28
NP	67.57	56.81	19

77,966.35 0.00 ( 0.00%)

53,790.86 -21.99 (-0.04%)

7,769.71 20.51 (0.26%)

67,546.56 576.34 (0.86%)

10,825.49 -18.70 (-0.17%)

95.28 0.13 (0.14%)

110.05 0.08 (0.07%)

128.64 0.30 (0.23%)

0.60 0.00 (-0.45%)